Stay updated on Chemo +/- Nivolumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Chemo +/- Nivolumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Chemo +/- Nivolumab in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Interventions header was reformatted. The page now notes that recruitment has ended and the revision is updated to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-15T08:20:26.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision tag updated to v3.5.5, replacing the previous v3.5.4.
    Difference
    0.0%
    Check dated 2026-06-08T03:44:59.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    No additions or deletions were provided, so there is nothing to summarize for this page.
    Difference
    0.0%
    Check dated 2026-05-24T14:34:08.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.5.4, replacing the previous v3.5.3. This indicates an update to the study record on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-05-17T10:23:27.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page revision label has been updated from v3.5.2 to v3.5.3, indicating a site/version maintenance update rather than a change to the clinical study information presented.
    Difference
    0.0%
    Check dated 2026-04-25T18:47:02.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-18T13:41:29.000Z thumbnail image

Stay in the know with updates to Chemo +/- Nivolumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Chemo +/- Nivolumab in NSCLC Clinical Trial page.